Teladoc Health, Inc. (NYSE:TDOC) Receives $12.24 Consensus PT from Analysts

Teladoc Health, Inc. (NYSE:TDOC) has earned an average recommendation of “Hold” from the twenty-one research firms that are covering the stock, Marketbeat reports. Fourteen analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $12.24.

Several research firms have commented on TDOC. Royal Bank of Canada increased their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Barclays increased their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Evercore ISI lifted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Piper Sandler reiterated an “overweight” rating and set a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Finally, TD Cowen lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.95% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently modified their holdings of TDOC. Signaturefd LLC boosted its holdings in Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after buying an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health in the second quarter valued at $29,000. Versant Capital Management Inc raised its position in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the period. Blue Trust Inc. boosted its stake in shares of Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after acquiring an additional 1,854 shares in the last quarter. Finally, Doheny Asset Management CA acquired a new stake in shares of Teladoc Health during the 2nd quarter valued at about $46,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of NYSE:TDOC opened at $9.79 on Thursday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of -1.70 and a beta of 1.01. The firm has a 50 day moving average of $9.94 and a 200 day moving average of $9.04. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.16.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. On average, sell-side analysts predict that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.